IL-15 shows potential in enhancing NK cell-mediated anti-tumor activity (161, 162), while IL-18 is associated with poor survival outcomes due to its role in increasing immunosuppressive NK cells and upregulating PD-1 expression. This evidence concerns the gene IL18 and neoplasm.